Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 1
2013 1
2014 1
2018 1
2023 1
2024 1
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Results by year

Filters applied: . Clear all
Page 1
Xanthohumol in XERME(), a xanthohumol-enriched roasted malt extract, and protection of DNA from oxidative damage: evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006.
EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA); Turck D, Bresson JL, Burlingame B, Dean T, Fairweather-Tait S, Heinonen M, Hirsch-Ernst KI, Mangelsdorf I, McArdle HJ, Naska A, Neuhäuser-Berthold M, Nowicka G, Pentieva K, Sanz Y, Sjödin A, Stern M, Tomé D, Van Loveren H, Vinceti M, Willatts P, Martin A, Strain SJ, Siani A. EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA), et al. EFSA J. 2018 Mar 13;16(3):e05192. doi: 10.2903/j.efsa.2018.5192. eCollection 2018 Mar. EFSA J. 2018. PMID: 32625830 Free PMC article.
Following an application from TA-XAN AG, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 via the Competent Authority of Germany, the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) was asked to deliver …
Following an application from TA-XAN AG, submitted for authorisation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/ …
Beer and beer compounds: physiological effects on skin health.
Chen W, Becker T, Qian F, Ring J. Chen W, et al. J Eur Acad Dermatol Venereol. 2014 Feb;28(2):142-50. doi: 10.1111/jdv.12204. Epub 2013 Jun 27. J Eur Acad Dermatol Venereol. 2014. PMID: 23802910 Review.
The extracts of these ingredients, especially the hops, contain an abundance of polyphenols such as kaempferol, quercetin, tyrosol, ferulic acid, xanthohumol/isoxanthohumol/8-prenylnaringenin, alpha-bitter acids like humulone and beta-bitter acids like lupulone. 8-prenylna …
The extracts of these ingredients, especially the hops, contain an abundance of polyphenols such as kaempferol, quercetin, tyrosol, ferulic …
A review of animal and human studies for management of benign prostatic hyperplasia with natural products: perspective of new pharmacological agents.
Azimi H, Khakshur AA, Aghdasi I, Fallah-Tafti M, Abdollahi M. Azimi H, et al. Inflamm Allergy Drug Targets. 2012 Jun;11(3):207-21. doi: 10.2174/187152812800392715. Inflamm Allergy Drug Targets. 2012. PMID: 22512478 Review.
RESULTS: According to the studies, some of the substantial effective constituents of the plants in treatment of BPH are oenothein B, icaritin, xanthohumol, diarylheptanoid, 2,6,4'-trihydroxy-4-methoxybenzophenone, emodin, fatty acids, atraric acid, n-butylbenzene-sulfonami …
RESULTS: According to the studies, some of the substantial effective constituents of the plants in treatment of BPH are oenothein B, icariti …
Xanthohumol attenuates collagen synthesis in scleroderma skin fibroblasts by ROS/Nrf2/TGFbeta1/Smad3 pathway.
Xiao Y, Huang Z, Wang Y, Wang Y, Yu L, Yang J, Zou H, Wan W, Yang X. Xiao Y, et al. Eur J Pharmacol. 2024 Jan 15;963:176227. doi: 10.1016/j.ejphar.2023.176227. Epub 2023 Dec 8. Eur J Pharmacol. 2024. PMID: 38072040
Skin fibrosis, the most obvious clinical manifestation of systemic sclerosis (SSc), has a high unmet need for treatment. Xanthohumol (Xn) has been shown to have beneficial effects on fibrotic diseases, but its efficacy in SSc remains unreported. ...
Skin fibrosis, the most obvious clinical manifestation of systemic sclerosis (SSc), has a high unmet need for treatment. Xanthohumol …
Xanthohumol inhibits IL-12 production and reduces chronic allergic contact dermatitis.
Cho YC, You SK, Kim HJ, Cho CW, Lee IS, Kang BY. Cho YC, et al. Int Immunopharmacol. 2010 May;10(5):556-61. doi: 10.1016/j.intimp.2010.02.002. Epub 2010 Feb 6. Int Immunopharmacol. 2010. PMID: 20144742
Xanthohumol (XN) and its related compounds were evaluated for their effects on modulating the production of interleukin (IL)-12, the most important factor driving T helper 1 immune responses. XN showed the strongest inhibitory effect on IL-12 production in macrophages stim …
Xanthohumol (XN) and its related compounds were evaluated for their effects on modulating the production of interleukin (IL)-12, the …